Enterprise Value
91.12M
Cash
259.2M
Avg Qtr Burn
-22.64M
Short % of Float
10.96%
Insider Ownership
13.74%
Institutional Own.
59.40%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CB-011 Details Blood cancer, Cancer, Multiple myeloma | Phase 1 Data readout | |
CB-010 Details Non-Hodgkin lymphoma, Cancer, Blood cancer | Phase 1 Data readout | |
CB-012 Details Acute myeloid leukemia | Phase 1 Initiation |